Edward L C Pritchett Selected Research

azimilide

2/2008	Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias.
7/2006	Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease.
5/2006	Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.
7/2004	Symptomatic arrhythmia recurrence as an outcome in clinical trials of antiarrhythmic drug therapy.
9/2003	Azimilide for atrial fibrillation: clinical trial results and implications.
9/2003	Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
3/2003	Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide.
4/2002	Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
4/2002	Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward L C Pritchett Research Topics

Disease

13	Atrial Fibrillation 01/2016 - 04/2002
7	Cardiac Arrhythmias (Arrythmia) 02/2008 - 03/2003
5	Atrial Flutter (Flutter, Atrial) 01/2016 - 04/2002
3	Torsades de Pointes (Torsade de Pointes) 01/2016 - 09/2003
3	Ventricular Tachycardia 02/2008 - 04/2002
2	Heart Diseases (Heart Disease) 07/2006 - 05/2006
1	Ventricular Fibrillation 01/2016
1	Tachycardia (Tachyarrhythmias) 01/2016
1	Atrioventricular Block 03/2008
1	Dysgeusia (Parageusia) 03/2008
1	Hypotension (Low Blood Pressure) 03/2008
1	Cardiogenic Shock 03/2008
1	Sneezing 03/2008
1	Headache (Headaches) 09/2003
1	Infarction (Infarctions) 09/2003
1	Infections 09/2003
1	Neutropenia 09/2003
1	Diarrhea 09/2003
1	Asthenia 09/2003
1	Dizziness (Lightheadedness) 09/2003

Drug/Important Bio-Agent (IBA)

9	azimilideIBA 02/2008 - 04/2002
7	Anti-Arrhythmia AgentsIBA 01/2016 - 04/2002
2	Propafenone (Rythmol)FDA LinkGeneric 07/2004 - 10/2003
1	vanoxerine (I 893)IBA 01/2016
1	vernakalantIBA 03/2008
1	Clopidogrel (Plavix)FDA Link 01/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2008
1	AnticoagulantsIBA 01/2008
1	Flecainide (Tambocor)FDA LinkGeneric 07/2004
1	Verapamil (Calan)FDA LinkGeneric 07/2004
1	Digoxin (Digitek)FDA LinkGeneric 07/2004
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 07/2004
1	Delayed-Action PreparationsIBA 10/2003
1	Pharmaceutical PreparationsIBA 03/2003

Therapy/Procedure

2	Therapeutics 07/2004 - 03/2003
1	Electric Countershock (Cardioversion) 01/2016